Ovarian cancer is a serious disease that often returns after initial treatment. A new narrative review explores how the cancer uses energy to survive and grow. The authors suggest that focusing on glycolysis, a specific way cells make energy, could help design better treatments. However, the current understanding is incomplete. The review points out that the cancer can switch to other energy paths when blocked. This makes it hard to stop the disease with just one drug. Without enough data on specific markers, doctors cannot easily pick the right combination of therapies for each person. The study notes that we lack sufficient clinical validation for these new ideas. This means we cannot yet say these strategies will work in real hospitals. The authors warn that metabolic differences between patients complicate the picture. We need more proof before we can trust these approaches to save lives.
Glycolysis-centered understanding of ovarian cancer may support biomarker-guided combination strategies and improve translational therapeutic designNew review suggests metabolic pathways in ovarian cancer need better tools to treat
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Note that glycolysis-centered understanding may support biomarker-guided strategies but lacks clinical validation.
This narrative review addresses the topic of glycolysis-centered understanding of ovarian cancer. The authors synthesize arguments suggesting that this perspective may support biomarker-guided combination strategies and improve translational therapeutic design. The scope covers potential pathways for future research rather than reporting specific trial data or patient outcomes.
The review highlights several key limitations that affect the certainty of these conclusions. These include metabolic heterogeneity, compensatory pathway activation, limited biomarkers, and insufficient clinical validation. These factors suggest that current evidence is not yet robust enough to drive widespread clinical adoption of specific glycolysis-targeted interventions.
Regarding safety, adverse events, serious adverse events, discontinuations, and tolerability were not reported in this source. The review does not provide specific numerical data on efficacy or safety profiles for any medication.
The practice relevance is that a glycolysis-centered understanding of ovarian cancer may support biomarker-guided combination strategies and improve translational therapeutic design. Clinicians should interpret these findings as conceptual guidance rather than established treatment protocols, given the noted gaps in clinical validation.
What this means for you:
Current metabolic tools for ovarian cancer are too limited to guide effective combination therapies. More on Cancer
Follicular T cell subsets and tertiary lymphoid structures may guide immunotherapy in ovarian cancer
New immune targets offer hope for ovarian cancer patients
This narrative review synthesizes evidence on follicular T cell subsets, tertiary lymphoid structures, and other immune features in ovarian …
A review highlights new immune system features that could help doctors predict treatment success and find better ways to fight ovarian cance…
Review of ovarian cancer treatments including olaparib, bevacizumab, and durvalumab discusses limitations and biomarkers
New drug combos target hidden cancer switches to stop resistance
This narrative review examines ovarian cancer management involving olaparib, bevacizumab, and durvalumab.
Hidden chemical changes in ovarian cancer cells help them hide from drugs, but new combinations might finally stop them from adapting and gr…
Narrative review on precision prevention for women with inherited gynecologic cancer susceptibility
New Plan Cuts Cancer Risk for High-Risk Women
This narrative review addresses ovarian, endometrial, and fallopian tube cancer in women with inherited gynecologic cancer susceptibility.
Women with strong family histories of ovarian or uterine cancer can now take smarter, personalized steps to reduce their risk — and it’s cha…
Narrative review links microbiome dysbiosis to gynecological cancer pathogenesis and potential therapeutic applications
Microbiome changes may help explain how gynecological cancers start and grow
This narrative review examines the role of the human microbiome in gynecological malignancies, including cervical, ovarian, endometrial, vul…
New review suggests microbiome shifts could be key to understanding gynecological cancers, opening doors for better prevention and treatment…
View Original Abstract ↓
Ovarian cancer is characterized by extensive peritoneal dissemination, frequent recurrence, and chemoresistance. Glycolytic reprogramming has emerged as a central metabolic adaptation in ovarian cancer, but its significance extends beyond increased glucose consumption. In this review, we summarize how key glycolytic regulators, including GLUT1, HK2, PFKFB3, PDK1, and LDHA, are controlled by oncogenic, microenvironmental, and non-coding RNA-mediated pathways to reshape tumor metabolism. We emphasize that glycolysis supports ovarian cancer progression by promoting biosynthetic activity, redox balance, invasive dissemination, stem-like plasticity, and therapy resistance. Importantly, this review highlights glycolysis as an immunometabolic regulator of the ovarian tumor microenvironment. Lactate accumulation, macrophage reprogramming, IL-1β/NF-κB signaling, PD-L1 induction, and CD4+ T-cell metabolic remodeling collectively contribute to immune escape. Targeting glycolytic pathways may therefore provide therapeutic opportunities not only to suppress tumor growth but also to enhance chemotherapy and immunotherapy. However, metabolic heterogeneity, compensatory pathway activation, limited biomarkers, and insufficient clinical validation remain major challenges. A glycolysis-centered understanding of ovarian cancer may support biomarker-guided combination strategies and improve translational therapeutic design.
Budesonide-glycopyrronium-formoterol fumarate dihydrate improved lung function and reduced severe exacerbations versus budesonide-formoterol in inadequately controlled asthma
New Asthma Drug Cuts Attacks Without Recent Crisis
Related in Allergy & Immunology
Advanced diagnostic techniques including molecular profiling and AI offer evolving strategies for allergic rhinitis management
New Diagnostic Methods Show Progress in Allergic Rhinitis Care
This systematic review examines the evolution of clinical examination techniques for allergic rhinitis from conventional methods to advanced…
Advanced tools like artificial intelligence and molecular testing are evolving how doctors identify and manage allergic rhinitis symptoms.
Omics technologies identify inflammatory, fibrotic, and metabolic programs in secondary lymphedema for target identification
New data helps identify biological targets for secondary lymphedema
This systematic review evaluates the role of omics technologies in identifying biomarkers and therapeutic targets for secondary lymphedema. …
Researchers are moving beyond simple physical descriptions of lymphedema to find specific biological markers that could lead to better treat…
FTO-targeted strategies currently lack clinical evaluation and rely on preclinical evidence for cancer treatment
Targeting the FTO Protein May Improve Cancer Treatment Outcomes in Future Trials
This systematic review examines the role of FTO as a context-dependent epitranscriptomic regulator in cancer. The authors conclude that whil…
Scientists are looking at how targeting a specific protein called FTO could help patients who receive immunotherapy for cancer.
Existing food security scales lack the ability to capture unique cultural dimensions for immigrant populations
Cultural Food Security Matters for Immigrant and Refugee Communities
This scoping review of 18 studies synthesizes definitions and indicators of cultural food security for immigrants and refugees. The authors …
Standard food security measures often fail to capture the cultural needs of immigrants, highlighting a need for more inclusive community sup…
From Other Specialties
Serotonergic antidepressants and prolactin-elevating antipsychotics are associated with higher burdens of sexual dysfunction
Certain medications for depression and psychosis can cause sexual issues
This narrative review examines the impact of antidepressants and antipsychotics on sexual dysfunction in patients with depressive and psycho…
Some common treatments for mood and psychotic disorders may impact a patient's sex life, quality of life, and their ability to stay on medic…
Structured exercise may improve blood pressure and outcomes in hypertensive disorders of pregnancy
Structured exercise may help manage high blood pressure during pregnancy
This scoping review examines structured exercise interventions, including aerobic training, resistance training, stretching, and yoga, for w…
New research suggests that structured exercises like yoga and resistance training could improve health for pregnant women with high blood pr…
LPC and LPA act as central hubs for lipid metabolism and inflammation in atherosclerosis
New research identifies key molecules driving inflammation in heart disease
This systematic review examines the role of lysophosphatidylcholine (LPC) and lysophosphatidic acid (LPA) in atherosclerosis. The authors co…
Scientists have identified how specific fats trigger inflammation and plaque buildup in the arteries to help guide future heart health treat…
Pulsed field ablation reduces procedure time compared to very high-power short-duration ablation in atrial fibrillation
Pulsed field ablation speeds up heart surgery for atrial fibrillation
This meta-analysis of 11 observational studies evaluated pulsed field ablation (PFA) against very high-power short-duration ablation (vHPSD)…
A newer technique called pulsed field ablation can significantly shorten procedure times for patients undergoing heart surgery to treat irre…